StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.70−0.06 (-1.60%)

Close on Nov 17, 2026Market cap $464.39MP/E –Yield –

Aquestive Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aquestive Therapeutics's total debt was $50.69M at Jun 30, 2026. For fiscal 2025 it was $37.51M, up 15.4% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.51M+15.4%
FY2024Dec 31, 2024$32.50M+18.1%
FY2023Dec 31, 2023$27.51M-17.8%
FY2022Dec 31, 2022$33.45M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$50.69M+84.3%
Q1 FY2026Mar 31, 2026$25.10M-25.0%
Q4 FY2025Dec 31, 2025$37.51M–
Q4 FY2024Dec 31, 2024$32.50M–
Q4 FY2023Dec 31, 2023$27.51M–
Q4 FY2022Dec 31, 2022$33.45M–

More Aquestive Therapeutics figures

See a number that looks wrong?